Wednesday, 18 December 2013

Pain drugs used in prostate gland removal linked to cancer outcome

The methods used to anesthetize prostate cancer patients and control pain when their prostate glands are surgically removed for adenocarcinoma may affect their long-term cancer outcomes, a study led by Mayo Clinic has found. Opioids, painkillers commonly given during and after surgery, may suppress the immune system's ability to fight cancer cells. Read more here.

Study mentioned: Scavonetto F, et al. Association between neuraxial analgesia, cancer progression, and mortality after radical prostatectomy: a large, retrospective matched cohort study. Br J Anaesth (2013) First published online: December 16, 2013

No comments:

Post a Comment